Federico La Manna

1.3k total citations
27 papers, 740 citations indexed

About

Federico La Manna is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Federico La Manna has authored 27 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Federico La Manna's work include Bone health and treatments (7 papers), Cancer Cells and Metastasis (7 papers) and Sarcoma Diagnosis and Treatment (4 papers). Federico La Manna is often cited by papers focused on Bone health and treatments (7 papers), Cancer Cells and Metastasis (7 papers) and Sarcoma Diagnosis and Treatment (4 papers). Federico La Manna collaborates with scholars based in Italy, United States and Switzerland. Federico La Manna's co-authors include Guillaume Martin, Thomas Lenormand, Sofia Karkampouna, George N. Thalmann, Chiara Liverani, Toni Ibrahim, Laura Mercatali, Alberto Bongiovanni, Dino Amadori and Alessandro De Vita and has published in prestigious journals such as Nature Communications, Oncogene and Scientific Reports.

In The Last Decade

Federico La Manna

27 papers receiving 734 citations

Peers

Countries citing papers authored by Federico La Manna

Since Specialization

Citations

This map shows the geographic impact of Federico La Manna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico La Manna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico La Manna more than expected).

Fields of papers citing papers by Federico La Manna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico La Manna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico La Manna. The network helps show where Federico La Manna may publish in the future.

Co-authorship network of co-authors of Federico La Manna

This figure shows the co-authorship network connecting the top 25 collaborators of Federico La Manna. A scholar is included among the top collaborators of Federico La Manna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico La Manna. Federico La Manna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TRPM4 contributes to cell death in prostate cancer tumor spheroids, and to extravasation and metastasis in a zebrafish xenograft model system 2025 ·Molecular Oncology ·Florian Bochen, (unknown), Federico La Manna, (unknown), (unknown), Marianna Kruithof‐de Julio, Christine Peinelt	2
2	CRIPTO’s multifaceted role in driving aggressive prostate cancer unveiled by in vivo, organoid, and patient data 2024 ·Oncogene ·(unknown), Simone de Brot, Eugenio Zoni, (unknown), Antonella Brunello, (unknown), Marta De Menna, Federico La Manna, (unknown), Irena Klima, David W. Freeman, (unknown), Domenico A. Cristaldi, Olivier T. Guenat, Boudewijn P. T. Kruithof, Benjamin T. Spike, Panagiotis Chouvardas, Marianna Kruithof‐de Julio	3
3	Bladder cancer organoids as a functional system to model different disease stages and therapy response 2023 ·Nature Communications ·(unknown), (unknown), (unknown), Mirjam Kiener, Tarcisio Fedrizzi, Federico La Manna, Sofia Karkampouna, Panagiotis Chouvardas, Vera Genitsch, (unknown), Éva Compérat, Irena Klima, Paola Gasperini, Bernhard Kiss, Roland Seiler, Francesca Demichelis, George N. Thalmann, Marianna Kruithof‐de Julio	49
4	Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union 2023 ·Gene ·Federico La Manna, (unknown), Peter Kloen, André J. van Wijnen, George N. Thalmann, Marianna Kruithof‐de Julio, Panagiotis Chouvardas	3
5	Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer 2022 ·Cancer Letters ·Juening Kang, Federico La Manna, Francesco Bonollo, Natalie Sampson, Ian Alberts, Clemens Mingels, Ali Afshar‐Oromieh, George N. Thalmann, Sofia Karkampouna	95
6	A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection 2022 ·Communications Biology ·Pasquale Laise, Megan L. Stanifer, (unknown), Xiaoyun Sun, Sergio Triana, Patricio Doldan, Federico La Manna, Marta De Menna, Ronald Realubit, Sergey Pampou, Charles Karan, Theodore Alexandrov, Marianna Kruithof‐de Julio, Andrea Califano, Steeve Boulant, Mariano J. Alvarez	3
7	Lineage‐specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture 2021 ·Molecular Oncology ·Chiara Liverani, Alessandro De Vita, Chiara Spadazzi, Giacomo Miserocchi, Claudia Cocchi, Alberto Bongiovanni, (unknown), Federico La Manna, Francesco� Fabbri, Michela Tebaldi, Dino Amadori, Ennio Tasciotti, Giovanni Martinelli, Laura Mercatali, Toni Ibrahim	12
8	Occult lesion localization by indocyanine green fluorescence for nonpalpable breast cancer 2020 ·The Breast Journal ·(unknown), (unknown), Federico La Manna, E. Pages, (unknown), Hélène Perrochia, Patrice Taourel, Noémie Ranisavljevic, (unknown)	2
9	Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity 2020 ·Frontiers in Oncology ·Federico La Manna, Marta De Menna, Nikhil Patel, Sofia Karkampouna, Maria Rosaria De Filippo, Irena Klima, Peter Kloen, Lijkele Beimers, George N. Thalmann, Rob C.M. Pelger, Estela Jacinto, Marianna Kruithof‐de Julio	32
10	A biomimetic 3D model of hypoxia-driven cancer progression 2019 ·Scientific Reports ·Chiara Liverani, Alessandro De Vita, Silvia Minardi, Yibin Kang, Laura Mercatali, Dino Amadori, Alberto Bongiovanni, Federico La Manna, Toni Ibrahim, Ennio Tasciotti	61
11	Metastases in Prostate Cancer 2018 ·Cold Spring Harbor Perspectives in Medicine ·Federico La Manna, Sofia Karkampouna, Eugenio Zoni, Marta De Menna, Janine Hensel, George N. Thalmann, Marianna Kruithof‐de Julio	56
12	CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer 2017 ·Oncogene ·Eugenio Zoni, (unknown), Sofia Karkampouna, Zoraide Granchi, Esther I. Verhoef, Federico La Manna, Jonathan A. Kelber, Rob C.M. Pelger, Michael D. Henry, B. Ewa Snaar‐Jagalska, Geert J.L.H. van Leenders, Lijkele Beimers, Peter Kloen, Peter C. Gray, Gabri van der Pluijm, Marianna Kruithof‐de Julio	35
13	Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition 2017 ·International Journal of Molecular Sciences ·Laura Mercatali, Federico La Manna, Giacomo Miserocchi, Chiara Liverani, Alessandro De Vita, Chiara Spadazzi, Alberto Bongiovanni, Federica Recine, Dino Amadori, Martina Ghetti, Toni Ibrahim	26
14	RANKL: A promising circulating marker for bone metastasis response 2016 ·Oncology Letters ·Toni Ibrahim, Marianna Ricci, Emanuela Scarpi, Alberto Bongiovanni, (unknown), Nada Riva, Chiara Liverani, Alessandro De Vita, Federico La Manna, Devil Oboldi, Patrizia Serra, Flavia Foca, Lorenzo Cecconetto, Dino Amadori, Laura Mercatali	25
15	Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model 2016 ·Annals of Oncology ·Chiara Liverani, Federico La Manna, Arwin Groenewoud, Laura Mercatali, Gabri van der Pluijm, Federica Pieri, Davide Cavaliere, (unknown), Chiara Spadazzi, Giacomo Miserocchi, Alberto Bongiovanni, Federica Recine, Nada Riva, D. Amadori, Ennio Tasciotti, (unknown), Valentina Fausti, B. Ewa Snaar‐Jagalska, Toni Ibrahim	4
16	First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma 2015 ·OncoTargets and Therapy ·Alberto Bongiovanni, Nada Riva, Marianna Ricci, Chiara Liverani, Federico La Manna, Alessandro De Vita, Toni Ibrahim, Flavia Foca, Laura Mercatali, Dino Amadori, (unknown)	30
17	Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report 2015 ·BMC Cancer ·Alberto Bongiovanni, Nada Riva, Marianna Ricci, Laura Mercatali, Chiara Liverani, Federico La Manna, Alessandro De Vita, Davide Cavaliere, Federica Pieri, Devil Oboldi, Giorgio Maria Verdecchia, Dino Amadori, Toni Ibrahim	5
18	CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems 2014 ·Bone ·Chiara Liverani, Laura Mercatali, Chiara Spadazzi, Federico La Manna, Alessandro De Vita, Nada Riva, Sebastiano Calpona, Marianna Ricci, Alberto Bongiovanni, (unknown), Michele Zanoni, Francesco� Fabbri, Wainer Zoli, Dino Amadori, Toni Ibrahim	31
19	The high‐throughput yeast deletion fitness data and the theories of dominance 2012 ·Journal of Evolutionary Biology ·Federico La Manna, Romain Gallet, Guillaume Martin, Thomas Lenormand	18
20	Alkaline phosphatase, cholinesterase and aspartic aminopherase activity in the subretinal fluid in retinal ablation. 1968 ·PubMed ·Federico La Manna, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact